DK2380583T3 - Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser - Google Patents
Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelserInfo
- Publication number
- DK2380583T3 DK2380583T3 DK11161614.0T DK11161614T DK2380583T3 DK 2380583 T3 DK2380583 T3 DK 2380583T3 DK 11161614 T DK11161614 T DK 11161614T DK 2380583 T3 DK2380583 T3 DK 2380583T3
- Authority
- DK
- Denmark
- Prior art keywords
- alzheimer
- beta
- disease
- treatment
- amyloid protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53140603P | 2003-12-18 | 2003-12-18 | |
US55434204P | 2004-03-17 | 2004-03-17 | |
US61561404P | 2004-09-30 | 2004-09-30 | |
US11/016,706 US7384910B2 (en) | 1997-10-08 | 2004-12-16 | Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
EP09015653.0A EP2172208B1 (en) | 2003-12-18 | 2004-12-17 | Small peptides for the treatment of Alzheimer's disease and other Beta-Amyloid protein fibrillogenesis disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2380583T3 true DK2380583T3 (da) | 2013-12-02 |
Family
ID=34714497
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09015653.0T DK2172208T3 (da) | 2003-12-18 | 2004-12-17 | Små peptider til behandling af alzheimers sygdom og andre beta-amyloidprotein- fibrillogeneseforstyrrelser |
DK11161614.0T DK2380583T3 (da) | 2003-12-18 | 2004-12-17 | Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09015653.0T DK2172208T3 (da) | 2003-12-18 | 2004-12-17 | Små peptider til behandling af alzheimers sygdom og andre beta-amyloidprotein- fibrillogeneseforstyrrelser |
Country Status (8)
Country | Link |
---|---|
US (2) | US7384910B2 (da) |
EP (3) | EP2172208B1 (da) |
JP (2) | JP4694506B2 (da) |
CA (2) | CA2550085C (da) |
DK (2) | DK2172208T3 (da) |
ES (2) | ES2437134T3 (da) |
PT (2) | PT2380583E (da) |
WO (1) | WO2005060683A2 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010012845A1 (es) * | 2008-08-01 | 2010-02-04 | Natraceutical, S.A. | Obtención de extractos de cacao ricos en peptidos bioactivos con actividad inhibidora de las enzimas eca y pep |
FR2940292B1 (fr) * | 2008-12-23 | 2013-05-10 | Isp Investments Inc | Peptides derives d'hmg-coa reductase et composition cosmetique et/ou pharmaceutique les contenant |
FR2940126B1 (fr) * | 2008-12-23 | 2013-05-10 | Isp Investments Inc | Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase |
WO2010138794A2 (en) | 2009-05-29 | 2010-12-02 | The University Of North Carolina At Chapel Hill | Regulation of sodium channels by plunc proteins |
JP5848768B2 (ja) | 2010-10-29 | 2016-01-27 | ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドRamot At Tel Aviv University Ltd. | インドール誘導体及びその製造方法 |
AU2012312520A1 (en) * | 2011-09-20 | 2014-05-08 | The University Of North Carolina At Chapel Hill | Regulation of sodium channels by PLUNC proteins |
CN102516359B (zh) * | 2011-12-08 | 2014-05-07 | 重庆大学 | 一种抗老年痴呆症先导化合物 |
WO2014039074A2 (en) * | 2012-09-04 | 2014-03-13 | The Board Of Trustees Of The Leland Stanford Junior University | Therapeutic compositions and related methods |
JP6660877B2 (ja) * | 2013-09-26 | 2020-03-11 | フォルシュングスツェントルム・ユーリッヒ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | アミロイド−β−結合性ペプチド、ならびにアルツハイマー型認知症の治療および診断のためのその使用 |
JP6455983B2 (ja) * | 2013-10-25 | 2019-01-23 | 国立大学法人神戸大学 | アミロイド分解能を有する人工ペプチドおよびその利用 |
EP2927687A1 (en) * | 2014-03-31 | 2015-10-07 | Ecole Polytechnique Federale de Lausanne (EPFL) | Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods |
JP2016040542A (ja) * | 2014-08-13 | 2016-03-24 | 学校法人金沢医科大学 | 認知症治療薬または認知症治療薬候補物質のスクリーニング方法 |
WO2016057795A1 (en) | 2014-10-08 | 2016-04-14 | The University Of North Carolina At Chapel Hill | Improved peptide inhibitors of sodium channels |
DE102015003503A1 (de) * | 2015-03-20 | 2016-09-22 | Forschungszentrum Jülich GmbH | Spezifisch Amyloid-Beta bindende Peptide und deren Verwendung für die Therapie und Diagnose der Alzheimerschen Demenz |
WO2016183277A1 (en) * | 2015-05-12 | 2016-11-17 | Northwestern University | Materials for tissue regeneration |
PT2017095250B (pt) | 2015-11-30 | 2021-08-06 | Univ De Coimbra | Peptídeos inibidores da bace1 para o tratamento de doenças neurológicas |
WO2017131468A1 (ko) | 2016-01-27 | 2017-08-03 | 경상대학교산학협력단 | 아디포넥틴 수용체 활성화 신규 펩티드를 유효성분으로 포함하는 신경질환의 예방, 개선 또는 치료용 조성물 |
KR102234027B1 (ko) * | 2018-05-09 | 2021-03-31 | 서울대학교산학협력단 | B형 간염 바이러스 유래 폴리펩티드 및 이의 항바이러스 용도 |
ES2821599A1 (es) * | 2019-10-24 | 2021-04-26 | Univ Del Pais Vasco / Euskal Herriko Unibertsitatea | Compuestos y metodos para el tratamiento de la enfermedad de alzheimer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6933280B2 (en) * | 1996-10-08 | 2005-08-23 | Gerardo Castillo | Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
AU4749297A (en) | 1996-10-08 | 1998-05-05 | University Of Washington | Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments |
-
2004
- 2004-12-16 US US11/016,706 patent/US7384910B2/en not_active Expired - Fee Related
- 2004-12-17 CA CA2550085A patent/CA2550085C/en not_active Expired - Fee Related
- 2004-12-17 WO PCT/US2004/042632 patent/WO2005060683A2/en active Search and Examination
- 2004-12-17 PT PT111616140T patent/PT2380583E/pt unknown
- 2004-12-17 DK DK09015653.0T patent/DK2172208T3/da active
- 2004-12-17 CA CA2800228A patent/CA2800228C/en not_active Expired - Fee Related
- 2004-12-17 JP JP2006545518A patent/JP4694506B2/ja not_active Expired - Fee Related
- 2004-12-17 EP EP09015653.0A patent/EP2172208B1/en not_active Not-in-force
- 2004-12-17 PT PT90156530T patent/PT2172208E/pt unknown
- 2004-12-17 EP EP04814775A patent/EP1699418A2/en not_active Withdrawn
- 2004-12-17 ES ES11161614.0T patent/ES2437134T3/es active Active
- 2004-12-17 EP EP11161614.0A patent/EP2380583B1/en not_active Not-in-force
- 2004-12-17 DK DK11161614.0T patent/DK2380583T3/da active
- 2004-12-17 ES ES09015653T patent/ES2434242T3/es active Active
-
2007
- 2007-04-02 US US11/732,226 patent/US7759311B2/en not_active Expired - Fee Related
-
2010
- 2010-12-24 JP JP2010287233A patent/JP5221633B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2550085C (en) | 2013-03-12 |
WO2005060683A2 (en) | 2005-07-07 |
EP2172208A1 (en) | 2010-04-07 |
DK2172208T3 (da) | 2013-10-28 |
JP4694506B2 (ja) | 2011-06-08 |
US20050244334A1 (en) | 2005-11-03 |
US20080227721A1 (en) | 2008-09-18 |
ES2434242T3 (es) | 2013-12-16 |
WO2005060683A3 (en) | 2007-04-12 |
US7759311B2 (en) | 2010-07-20 |
CA2800228C (en) | 2015-03-24 |
CA2550085A1 (en) | 2005-07-07 |
EP1699418A2 (en) | 2006-09-13 |
EP2172208B1 (en) | 2013-08-07 |
PT2172208E (pt) | 2013-11-11 |
JP2011093916A (ja) | 2011-05-12 |
ES2437134T3 (es) | 2014-01-09 |
JP5221633B2 (ja) | 2013-06-26 |
PT2380583E (pt) | 2013-11-29 |
US7384910B2 (en) | 2008-06-10 |
EP2380583A1 (en) | 2011-10-26 |
CA2800228A1 (en) | 2005-07-07 |
EP2380583B1 (en) | 2013-08-28 |
JP2007535494A (ja) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2380583T3 (da) | Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser | |
DK1303272T3 (da) | Benzothiazolderivater til behandling af Alzheimers sygdom og Parkinsons sygdom | |
DK2075007T3 (da) | Behandling af Alzheimers sygdom | |
DK1392287T3 (da) | Anvendelse af substituerede azetidinonderivater i behandlingen af Alzheimers sygdom | |
DK2527315T3 (da) | Forbindelser, præparater og fremgangsmåder til behandling af amyloide sygdomme og synukleinopatier, såsom Alzheimers sygdom, type 2-diabetes og Parkinsons sygdom | |
ATE542801T1 (de) | Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine | |
ATE417037T1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
DK1765388T3 (da) | Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil | |
DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
NO20026199L (no) | Forbindelser for behandling av Alzheimers sykdom | |
DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
ATE494279T1 (de) | Zur behandlung von durch crth2 vermittelten krankheiten geeignete pyrimidinderivate | |
DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
IS8135A (is) | Þríhringtengdar indólafleiður og notkun þeirra til að meðhöndla Alzheimers-sjúkdóm | |
IS8004A (is) | Aðferð við meðhöndlun á vægri vitsmunaskerðingu og til að fyrirbyggja eða tefja Alzheimers-sjúkdóminn | |
AU2003273213A8 (en) | Amyloid peptide inactivating enzyme to treat alzheimer's disease | |
DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
NO20053341D0 (no) | Hindring og behandling av Alzheimers sykdom. | |
IS7163A (is) | Aðferðir til meðhöndlunar á lungnasjúkdómi | |
DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
NO20060781L (no) | Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser | |
ATE330938T1 (de) | Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen | |
AU2003286530A8 (en) | Substituted peptides useful in the treatment of alzheimer's disease | |
DE60223674D1 (de) | Vektoren zur gesteigerten expression von vegf zur behandlung von krankheiten |